Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma

Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma:



Although checkpoint blockades have become widely used, the immunological impact in cancer patients, especially those with oral cavity squamous cell carcinoma (OCSCC), has not been well studied.